Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multi-Center, Randomized, Placebo-Controlled, Dose-Finding Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients

NCT04612413 is registered in ClinicalTrials.gov with Enlivex Therapeutics Ltd. as lead sponsor.

NCT NCT04612413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04612413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multi-Center, Randomized, Placebo-Controlled, Dose-Finding Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients
Lead sponsor
Enlivex Therapeutics Ltd.
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2020
Completion date
December 16, 2024
Enrollment
148 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

cholangitis acute, cholecystitis, acute, community-acquired pneumonia, intraabdominal infections, sepsis, urinary tract infections